Leadership

Company Leadership

Eva Kučerová, MD

Eva Kučerová, MD

Head of Regulatory Affairs, Qualified Person

Eva Kučerová received her degree at the Masaryk University Brno in microbiology and molecular biology. As of 2005, she has been involved in the area of research within the field of mesenchymal stem cells and cell cultivations. In the meantime, she has also participated in a variety of clinical studies and for a period of five years she has been working as a research fellow in treatments of leukaemia at the Faculty of Medicine at the Masaryk University Brno. In 2008 she was named the Head of the Cell Therapy Department at Tissue Bank at the University Hospital Brno. Since 2009 she has worked as Qualified Person and in the same year she has been appointed Head of the Department of Cell Transplants at the National Cell and Tissue Centre. She is also responsible for clinical trials.

Actively participating at national and international conferences, presenting new research findings, Eva Matějková is a renowned professional within the field of Advanced Therapies.

Serhiy Forostyak, MD, Ph.D.

Serhiy Forostyak, MD, Ph.D.

Chief Scientific Officer

Dr. Forostyak has graduated from a Faculty of Medicine at Ternopil’ State Medical University, Ukraine in 2005 (with honours). After receiving his first degree specialization in the field of general surgery (2008) Dr. Forostyak has continued his education at the 2nd Faculty of Medicine at Charles University in Prague and Institute of Experimental Medicine at Czech Academy of Sciences.

He has defended his doctoral thesis in 2012 and received a title PhD in Neuroscience. During his doctoral and postdoctoral years he has received several prestigious fellowships and awards (CORTEX: Marie Curie Early Stage Training Net; FENS Young Investigator Training Program; Czech Neuroscience Society award for best publication published by a Young Neuroscientist; Development of Research Teams for the BIOCEV; EUROCELLNET travel fellowship etc.) and underwent internship in prestigious universities (Cambridge University, UK; Katholieke Universiteit Leuven, Belgium; Neuroscience Institute Cavalieri Ottolenghi, Italy; University of Pittsburgh, USA). Dr. Forostyak’s research lays in the field of regenerative and translational medicine with a main focus on evaluation of regenerative potential of stem cells (mesenchymal stromal cells; embryonic stem cells; induced pluripotent stem cells etc.) and biomaterials, and their application to cure neurotrauma and neurodegenerative disorders. Current scientific record includes 22 publications (WOS) in prestigious international peer-reviewed journals, 3 book chapters and 3 papers are currently in press. Dr. Forostyak has been principal/co-principle investigator in several research projects. He is acting as a scientific evaluator of national and international grant agencies, but also contributes as a reviewer in prestigious scientific journals. He has been actively participating at numerous national and international conferences, but also acted as an organising committee member at several international meetings.

Petr Koška, M.Eng., MBA

Petr Koška, M.Eng., MBA

Chief Executive Officer

Petr Koška is Chief Executive Officer of PrimeCell Therapeutics Inc. and Vice-Chairman of the Board of Directors of the National Cell and Tissue Centre Inc. (one of the subsidiaries of PrimeCell Therapeutics). He joined PrimeCell Therapeutics in January 2013 holding a variety of leadership positions over the course of his career. Mr Koska is a well-known professional within the healthcare industry in the Czech Republic. He is a respected manager, who boasts of many years of experience leading large medical facilities.

Prior to his position in PrimeCell Therapeutics, since 2008 he was Chief Executive Officer at one of the largest university hospitals in the Czech Republic, namely, St. Anne´s University hospital Brno. In his previous position he gained knowledge of transferring medical science and research into clinical practice. Additionally, he was the head of a unique team of professionals who were involved with the development of an international centre of clinical research within the premises of St. Anne´s hospital, namely, International Clinical Research Center (ICRC). This centre was developed in co-operation with Mayo Clinic, Rochester, Minnesota, USA.

He started his professional career in 1996 at the University hospital Brno, where he held various leading positions until 2007, when he was elected General Director. In 1997 – 1998 he was one of the three key figures involved in the most unique plan in the healthcare industry in the Czech Republic up-to-date, which was the merger of university hospitals in the Brno region.

Mr Koška graduated at the Technical University Brno. Later, he obtained the MBA degree at Prague International Business School. Currently he is the candidate for PhD in business (DBA). In 2008 – 2012 he was a member of the scientific committee at the Medical faculty of Masaryk University in Brno.

Mgr. Iveta Minaříková

Mgr. Iveta Minaříková

Head of Amnio based products

Iveta Minaříková studied major Analytical Biochemistry, Faculty of Science, Masaryk University in Brno. During her studies she followed a research fellowship at University of Veterinary and Pharmaceutical Sciences in Brno where she participated in research focused on hypoglycemic prevention for her Bachelor thesis and later also Master thesis. The main theme was formulation and then testing of micro-pharmaceutical forms with high glucose content and semipermeable membrane which provided gradual release of glucose. This research had won competition Science Slam which popularizes current research and development and afterwards she took part in European final in Vienna.

After her studies she started her career as an analyst in company Oncomed Manufacturing, which produces cytostatic injections. She controlled the input material and the cytostatic injections during the production process but also after it. One of the necessary parts of her work was the validation of new production processes.

She joined our team with her experiences from pharmaceutical industry as a Research & Development Specialist and now she leads the development of new products and the area of processing.

Mgr. Igor Hlásenský

Mgr. Igor Hlásenský

Head of Lawyer Dept.

Legal matters of PrimeCell Therapeutics are in hands of a team of in-house lawyers led by Igor Hlásenský, young but well-experienced specialist in medical law as well as commercial and administrative law. Upon finishing his studies at the Faculty of Law of Masaryk University in Brno in 2010 he worked for a respected law firm and later moved up to the Ministry of Health to became a main lawyer, inspector, and deputy head of Inspectorate of narcotic drugs and psychotropic substances.

During his career Igor attended many conferences, trained people in legal consciousness and was a part of the European Commission delegation to Serbia for the purpose of bringing this country’s legislation into line with the European law. Igor is a major author of the text of the Czech Act On Drug Precursors and certain other general binding regulations and contributed significantly to terminate complicated and hyped cases.

Nowadays Igor is ranked among leading experts in legal obligations related to handling with tissues and cells and he strongly helps PrimeCell Therapeutics to conclude all the necessary contracts and conduct its activities in full compliance with the law.

Elen Šťastná, MD

Elen Šťastná, MD

Head of PR & Marketing Dept.

Dr. Elen Šťastná graduated from Charles University in Hradec Kralové in general medicine. After obtaining a first degree specialization in the field of general medicine she worked in this field until 2000. She has been involved in the projects of preventive medicine and projects aimed at improving the quality of life. She has worked at the Danish pharmaceutical and nutraceutical company Pharma Nord at managerial position in the field of education. Dr. Šťastná also provides consulting and advisory services in marketing communications activities, strategic planning and PR. She is The President of Soroptimist International Prague-world, prestigious women’s organizations with direct access to the UN and other international organizations, such as UNESCO and the Council of Europe. Soroptimist International seeks to improve access to health care, doctors, midwives and applies to the fight against the spread of AIDS and transmission of the disease from mother to newborn and improvement of living conditions of women and children.

Dr. Štastná is the founder of the AA Homolka Club at the Department of Pediatric Allergy and Clinical Immunology Hospital Homolka, whose activities contribute to the improvement of awareness and better care for children with allergy and asthma.

Board of Trustees

Václav Jirků, MD

Václav Jirků, MD

Member of the Board of Trustees
Ivo Kristen, M. Eng.

Ivo Kristen, M. Eng.

Member of the Board of Trustees
Michal Zahradníček, M. Eng., MBA

Michal Zahradníček, M. Eng., MBA

Chairman of the Board of Trustees

Michal Zahradníček, one of the founders of PrimeCell Therapeutics, is an investor and acts as a key figure in several high-tech companies in the Czech Republic and the Central and Eastern European region. He began his career in 1993, working as an economist for several international companies. Since 2001, he has been involved in investments in areas with high innovation potential. He acted as an advisor of the Ministry of Finance of the Slovak Republic, also taking part in health reform preparations. In 2004, he was awarded the title Manager of the Year for a Medium-Size Company and he was listed among the TOP 10 most successful Czech managers. Michal Zahradníček graduated from the Brno University of Technology. He then continued his studies at the Technical University in Darmstadt in Germany and at the Manchester Metropolitan University in the UK.